nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Cranial nerve paralysis—Methotrexate—bone cancer	0.127	0.127	CcSEcCtD
Nalidixic Acid—Papilloedema—Cisplatin—bone cancer	0.0841	0.0841	CcSEcCtD
Nalidixic Acid—Optic neuritis—Cisplatin—bone cancer	0.0435	0.0435	CcSEcCtD
Nalidixic Acid—Optic neuritis—Epirubicin—bone cancer	0.0223	0.0223	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Cisplatin—bone cancer	0.0215	0.0215	CcSEcCtD
Nalidixic Acid—Optic neuritis—Doxorubicin—bone cancer	0.0207	0.0207	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Cisplatin—bone cancer	0.0201	0.0201	CcSEcCtD
Nalidixic Acid—Blister—Epirubicin—bone cancer	0.0191	0.0191	CcSEcCtD
Nalidixic Acid—Blister—Doxorubicin—bone cancer	0.0176	0.0176	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Cisplatin—bone cancer	0.0147	0.0147	CcSEcCtD
Nalidixic Acid—Visual impairment—Cisplatin—bone cancer	0.0129	0.0129	CcSEcCtD
Nalidixic Acid—Erythema—Cisplatin—bone cancer	0.0117	0.0117	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methotrexate—bone cancer	0.011	0.011	CcSEcCtD
Nalidixic Acid—Leukopenia—Cisplatin—bone cancer	0.0105	0.0105	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Epirubicin—bone cancer	0.0104	0.0104	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Epirubicin—bone cancer	0.0103	0.0103	CcSEcCtD
Nalidixic Acid—Convulsion—Cisplatin—bone cancer	0.0101	0.0101	CcSEcCtD
Nalidixic Acid—Diplopia—Epirubicin—bone cancer	0.00997	0.00997	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Doxorubicin—bone cancer	0.00966	0.00966	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Cisplatin—bone cancer	0.00955	0.00955	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00953	0.00953	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Cisplatin—bone cancer	0.00935	0.00935	CcSEcCtD
Nalidixic Acid—Diplopia—Doxorubicin—bone cancer	0.00923	0.00923	CcSEcCtD
Nalidixic Acid—Eosinophilia—Methotrexate—bone cancer	0.00912	0.00912	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Cisplatin—bone cancer	0.0087	0.0087	CcSEcCtD
Nalidixic Acid—Paraesthesia—Cisplatin—bone cancer	0.00857	0.00857	CcSEcCtD
Nalidixic Acid—Eosinophilia—Epirubicin—bone cancer	0.00853	0.00853	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Methotrexate—bone cancer	0.00841	0.00841	CcSEcCtD
Nalidixic Acid—Drowsiness—Methotrexate—bone cancer	0.00821	0.00821	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00814	0.00814	CcSEcCtD
Nalidixic Acid—Eosinophilia—Doxorubicin—bone cancer	0.0079	0.0079	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Epirubicin—bone cancer	0.00787	0.00787	CcSEcCtD
Nalidixic Acid—Drowsiness—Epirubicin—bone cancer	0.00769	0.00769	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00762	0.00762	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Epirubicin—bone cancer	0.00753	0.00753	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Doxorubicin—bone cancer	0.00728	0.00728	CcSEcCtD
Nalidixic Acid—Drowsiness—Doxorubicin—bone cancer	0.00711	0.00711	CcSEcCtD
Nalidixic Acid—Visual impairment—Methotrexate—bone cancer	0.0071	0.0071	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00705	0.00705	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Methotrexate—bone cancer	0.00697	0.00697	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Doxorubicin—bone cancer	0.00697	0.00697	CcSEcCtD
Nalidixic Acid—Asthenia—Cisplatin—bone cancer	0.00685	0.00685	CcSEcCtD
Nalidixic Acid—Visual impairment—Epirubicin—bone cancer	0.00665	0.00665	CcSEcCtD
Nalidixic Acid—Diarrhoea—Cisplatin—bone cancer	0.00653	0.00653	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Epirubicin—bone cancer	0.00652	0.00652	CcSEcCtD
Nalidixic Acid—Erythema—Methotrexate—bone cancer	0.00642	0.00642	CcSEcCtD
Nalidixic Acid—Visual impairment—Doxorubicin—bone cancer	0.00615	0.00615	CcSEcCtD
Nalidixic Acid—Vomiting—Cisplatin—bone cancer	0.00607	0.00607	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Doxorubicin—bone cancer	0.00604	0.00604	CcSEcCtD
Nalidixic Acid—Rash—Cisplatin—bone cancer	0.00602	0.00602	CcSEcCtD
Nalidixic Acid—Dermatitis—Cisplatin—bone cancer	0.00601	0.00601	CcSEcCtD
Nalidixic Acid—Erythema—Epirubicin—bone cancer	0.00601	0.00601	CcSEcCtD
Nalidixic Acid—Vertigo—Methotrexate—bone cancer	0.00577	0.00577	CcSEcCtD
Nalidixic Acid—Leukopenia—Methotrexate—bone cancer	0.00574	0.00574	CcSEcCtD
Nalidixic Acid—Nausea—Cisplatin—bone cancer	0.00567	0.00567	CcSEcCtD
Nalidixic Acid—Convulsion—Methotrexate—bone cancer	0.00556	0.00556	CcSEcCtD
Nalidixic Acid—Erythema—Doxorubicin—bone cancer	0.00556	0.00556	CcSEcCtD
Nalidixic Acid—Arthralgia—Methotrexate—bone cancer	0.00546	0.00546	CcSEcCtD
Nalidixic Acid—Vertigo—Epirubicin—bone cancer	0.0054	0.0054	CcSEcCtD
Nalidixic Acid—Leukopenia—Epirubicin—bone cancer	0.00538	0.00538	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methotrexate—bone cancer	0.00524	0.00524	CcSEcCtD
Nalidixic Acid—Convulsion—Epirubicin—bone cancer	0.0052	0.0052	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Methotrexate—bone cancer	0.00513	0.00513	CcSEcCtD
Nalidixic Acid—Arthralgia—Epirubicin—bone cancer	0.00511	0.00511	CcSEcCtD
Nalidixic Acid—Vertigo—Doxorubicin—bone cancer	0.00499	0.00499	CcSEcCtD
Nalidixic Acid—Leukopenia—Doxorubicin—bone cancer	0.00497	0.00497	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Epirubicin—bone cancer	0.0049	0.0049	CcSEcCtD
Nalidixic Acid—Convulsion—Doxorubicin—bone cancer	0.00481	0.00481	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Epirubicin—bone cancer	0.0048	0.0048	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00477	0.00477	CcSEcCtD
Nalidixic Acid—Arthralgia—Doxorubicin—bone cancer	0.00473	0.00473	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methotrexate—bone cancer	0.0047	0.0047	CcSEcCtD
Nalidixic Acid—Somnolence—Methotrexate—bone cancer	0.00466	0.00466	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Doxorubicin—bone cancer	0.00454	0.00454	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00447	0.00447	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Doxorubicin—bone cancer	0.00444	0.00444	CcSEcCtD
Nalidixic Acid—Paraesthesia—Epirubicin—bone cancer	0.0044	0.0044	CcSEcCtD
Nalidixic Acid—Somnolence—Epirubicin—bone cancer	0.00436	0.00436	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methotrexate—bone cancer	0.00428	0.00428	CcSEcCtD
Nalidixic Acid—Urticaria—Methotrexate—bone cancer	0.00416	0.00416	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methotrexate—bone cancer	0.00414	0.00414	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00413	0.00413	CcSEcCtD
Nalidixic Acid—Paraesthesia—Doxorubicin—bone cancer	0.00407	0.00407	CcSEcCtD
Nalidixic Acid—Somnolence—Doxorubicin—bone cancer	0.00403	0.00403	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Epirubicin—bone cancer	0.00401	0.00401	CcSEcCtD
Nalidixic Acid—Urticaria—Epirubicin—bone cancer	0.00389	0.00389	CcSEcCtD
Nalidixic Acid—Abdominal pain—Epirubicin—bone cancer	0.00387	0.00387	CcSEcCtD
Nalidixic Acid—Asthenia—Methotrexate—bone cancer	0.00376	0.00376	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Doxorubicin—bone cancer	0.00371	0.00371	CcSEcCtD
Nalidixic Acid—Pruritus—Methotrexate—bone cancer	0.00371	0.00371	CcSEcCtD
Nalidixic Acid—Urticaria—Doxorubicin—bone cancer	0.0036	0.0036	CcSEcCtD
Nalidixic Acid—Abdominal pain—Doxorubicin—bone cancer	0.00359	0.00359	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methotrexate—bone cancer	0.00358	0.00358	CcSEcCtD
Nalidixic Acid—Asthenia—Epirubicin—bone cancer	0.00352	0.00352	CcSEcCtD
Nalidixic Acid—Pruritus—Epirubicin—bone cancer	0.00347	0.00347	CcSEcCtD
Nalidixic Acid—Dizziness—Methotrexate—bone cancer	0.00346	0.00346	CcSEcCtD
Nalidixic Acid—Diarrhoea—Epirubicin—bone cancer	0.00335	0.00335	CcSEcCtD
Nalidixic Acid—Vomiting—Methotrexate—bone cancer	0.00333	0.00333	CcSEcCtD
Nalidixic Acid—Rash—Methotrexate—bone cancer	0.0033	0.0033	CcSEcCtD
Nalidixic Acid—Dermatitis—Methotrexate—bone cancer	0.0033	0.0033	CcSEcCtD
Nalidixic Acid—Headache—Methotrexate—bone cancer	0.00328	0.00328	CcSEcCtD
Nalidixic Acid—Asthenia—Doxorubicin—bone cancer	0.00325	0.00325	CcSEcCtD
Nalidixic Acid—Dizziness—Epirubicin—bone cancer	0.00324	0.00324	CcSEcCtD
Nalidixic Acid—Pruritus—Doxorubicin—bone cancer	0.00321	0.00321	CcSEcCtD
Nalidixic Acid—Vomiting—Epirubicin—bone cancer	0.00312	0.00312	CcSEcCtD
Nalidixic Acid—Nausea—Methotrexate—bone cancer	0.00311	0.00311	CcSEcCtD
Nalidixic Acid—Diarrhoea—Doxorubicin—bone cancer	0.0031	0.0031	CcSEcCtD
Nalidixic Acid—Rash—Epirubicin—bone cancer	0.00309	0.00309	CcSEcCtD
Nalidixic Acid—Dermatitis—Epirubicin—bone cancer	0.00309	0.00309	CcSEcCtD
Nalidixic Acid—Headache—Epirubicin—bone cancer	0.00307	0.00307	CcSEcCtD
Nalidixic Acid—Dizziness—Doxorubicin—bone cancer	0.003	0.003	CcSEcCtD
Nalidixic Acid—Nausea—Epirubicin—bone cancer	0.00291	0.00291	CcSEcCtD
Nalidixic Acid—Vomiting—Doxorubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Nalidixic Acid—Rash—Doxorubicin—bone cancer	0.00286	0.00286	CcSEcCtD
Nalidixic Acid—Dermatitis—Doxorubicin—bone cancer	0.00286	0.00286	CcSEcCtD
Nalidixic Acid—Headache—Doxorubicin—bone cancer	0.00284	0.00284	CcSEcCtD
Nalidixic Acid—Nausea—Doxorubicin—bone cancer	0.00269	0.00269	CcSEcCtD
